PubMed

Quality-of-life evaluation in a clinical trial of zidovudine therapy in patients with mildly symptomatic HIV infection. The AIDS Clinical Trials Group.

Gelber RD, Lenderking WR, Cotton DJ, Cole BF, Fischl MA, Goldhirsch A, Testa MA.

Ann Intern Med. 1992 Jun 15;116(12 Pt 1):961-6.PMID: 1586104 [PubMed - indexed for MEDLINE]Related articles

Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials Group.

Lenderking WR, Gelber RD, Cotton DJ, Cole BF, Goldhirsch A, Volberding PA, Testa MA.

N Engl J Med. 1994 Mar 17;330(11):738-43.PMID: 7906386 [PubMed - indexed for MEDLINE]Related articlesFree article

The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.

Fischl MA, Richman DD, Hansen N, Collier AC, Carey JT, Para MF, Hardy WD, Dolin R, Powderly WG, Allan JD, et al.

Ann Intern Med. 1990 May 15;112(10):727-37.PMID: 1970466 [PubMed - indexed for MEDLINE]Related articles

Nevirapine, zidovudine, and didanosine compared with zidovudine and didanosine in patients with HIV-1 infection. A randomized, double-blind, placebo-controlled trial. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators.

D'Aquila RT, Hughes MD, Johnson VA, Fischl MA, Sommadossi JP, Liou SH, Timpone J, Myers M, Basgoz N, Niu M, Hirsch MS.

Ann Intern Med. 1996 Jun 15;124(12):1019-30.PMID: 8633815 [PubMed - indexed for MEDLINE]Related articlesFree article

Zidovudine twice daily in asymptomatic subjects with HIV infection and a high risk of progression to AIDS: a randomized, double-blind placebo-controlled study. The European-Australian Collaborative Group (Study 017)

Mulder JW, Cooper DA, Mathiesen L, Sandström E, Clumeck N, Gatell JM, French M, Donovan B, Gray F, Yeo JM, et al.

AIDS. 1994 Mar;8(3):313-21. Erratum in: AIDS 1994 Jun;8(6):following 859. PMID: 7913326 [PubMed - indexed for MEDLINE]Related articles

Clinical efficacy of monotherapy with stavudine compared with zidovudine in HIV-infected, zidovudine-experienced patients. A randomized, double-blind, controlled trial. Bristol-Myers Squibb Stavudine/019 Study Group.

Spruance SL, Pavia AT, Mellors JW, Murphy R, Gathe J Jr, Stool E, Jemsek JG, Dellamonica P, Cross A, Dunkle L.

Ann Intern Med. 1997 Mar 1;126(5):355-63.PMID: 9054279 [PubMed - indexed for MEDLINE]Related articlesFree article

Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection. HIV Protocol C91-253 Study Team.

Krown SE, Aeppli D, Balfour HH Jr.

J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Mar 1;20(3):245-54.PMID: 10077172 [PubMed - indexed for MEDLINE]Related articles

Evaluating the quality of life associated with rifabutin prophylaxis for Mycobacterium avium complex in persons with AIDS: combining Q-TWiST and multiattribute utility techniques.

Revicki DA, Simpson KN, Wu AW, LaVallee RL.

Qual Life Res. 1995 Aug;4(4):309-18.PMID: 7550179 [PubMed - indexed for MEDLINE]Related articles

A comparison of immediate with deferred zidovudine therapy for asymptomatic HIV-infected adults with CD4 cell counts of 500 or more per cubic millimeter. AIDS Clinical Trials Group.

Volberding PA, Lagakos SW, Grimes JM, Stein DS, Rooney J, Meng TC, Fischl MA, Collier AC, Phair JP, Hirsch MS, et al.

N Engl J Med. 1995 Aug 17;333(7):401-7.PMID: 7616988 [PubMed - indexed for MEDLINE]Related articlesFree article

A controlled trial of zidovudine in primary human immunodeficiency virus infection.

Kinloch-De Loës S, Hirschel BJ, Hoen B, Cooper DA, Tindall B, Carr A, Saurat JH, Clumeck N, Lazzarin A, Mathiesen L, et al.

N Engl J Med. 1995 Aug 17;333(7):408-13. Erratum in: N Engl J Med 1995 Nov 16;333(20):1367. PMID: 7616989 [PubMed - indexed for MEDLINE]Related articlesFree article

Combination and monotherapy with zidovudine and zalcitabine in patients with advanced HIV disease. The NIAID AIDS Clinical Trials Group.

Fischl MA, Stanley K, Collier AC, Arduino JM, Stein DS, Feinberg JE, Allan JD, Goldsmith JC, Powderly WG.

Ann Intern Med. 1995 Jan 1;122(1):24-32.PMID: 7985892 [PubMed - indexed for MEDLINE]Related articlesFree article

Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.

Moyle GJ, Bouza E, Antunes F, Smith D, Harris R, Warburg M, Walker M.

Antivir Ther. 1997 Dec;2(4):229-36.PMID: 11327442 [PubMed - indexed for MEDLINE]Related articles

The Alpha trial: European/Australian randomized double-blind trial of two doses of didanosine in zidovudine-intolerant patients with symptomatic HIV disease. Alpha International Coordinating Committee.

[No authors listed]

AIDS. 1996 Jul;10(8):867-80.PMID: 8828744 [PubMed - indexed for MEDLINE]Related articles

Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.

Englund JA, Baker CJ, Raskino C, McKinney RE, Petrie B, Fowler MG, Pearson D, Gershon A, McSherry GD, Abrams EJ, Schliozberg J, Sullivan JL.

N Engl J Med. 1997 Jun 12;336(24):1704-12.PMID: 9182213 [PubMed - indexed for MEDLINE]Related articlesFree article

The duration of zidovudine benefit in persons with asymptomatic HIV infection. Prolonged evaluation of protocol 019 of the AIDS Clinical Trials Group.

Volberding PA, Lagakos SW, Grimes JM, Stein DS, Balfour HH Jr, Reichman RC, Bartlett JA, Hirsch MS, Phair JP, Mitsuyasu RT, et al.

JAMA. 1994 Aug 10;272(6):437-42.PMID: 7913730 [PubMed - indexed for MEDLINE]Related articles

Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.

Cooper DA, Gatell JM, Kroon S, Clumeck N, Millard J, Goebel FD, Bruun JN, Stingl G, Melville RL, González-Lahoz J, et al.

N Engl J Med. 1993 Jul 29;329(5):297-303.PMID: 8100611 [PubMed - indexed for MEDLINE]Related articlesFree article

Functional status and well-being in a placebo-controlled trial of zidovudine in early symptomatic HIV infection.

Wu AW, Rubin HR, Mathews WC, Brysk LM, Bozzette SA, Hardy WD, Atkinson JH, Grant I, Spector SA, McCutchan JA, et al.

J Acquir Immune Defic Syndr. 1993 May;6(5):452-8.PMID: 8483109 [PubMed - indexed for MEDLINE]Related articles

Cost effectiveness analysis of early zidovudine treatment of HIV infected patients.

Oddone EZ, Cowper P, Hamilton JD, Matchar DB, Hartigan P, Samsa G, Simberkoff M, Feussner JR.

BMJ. 1993 Nov 20;307(6915):1322-5.PMID: 8257887 [PubMed - indexed for MEDLINE]Related articlesFree article

Interferon-alpha in patients with asymptomatic human immunodeficiency virus (HIV) infection. A randomized, placebo-controlled trial.

Lane HC, Davey V, Kovacs JA, Feinberg J, Metcalf JA, Herpin B, Walker R, Deyton L, Davey RT Jr, Falloon J, et al.

Ann Intern Med. 1990 Jun 1;112(11):805-11.PMID: 1971503 [PubMed - indexed for MEDLINE]Related articles

The effect of the interaction of acyclovir with zidovudine on progression to AIDS and survival. Analysis of data in the Multicenter AIDS Cohort Study.

Stein DS, Graham NM, Park LP, Hoover DR, Phair JP, Detels R, Ho M, Saah AJ.

Ann Intern Med. 1994 Jul 15;121(2):100-8.PMID: 8017721 [PubMed - indexed for MEDLINE]Related articlesFree article